Questions and answers

Does a biopsy make cancer spread?

A common worry, and what the evidence says about tumour cells "seeding" along the needle track

Updated: 28 October 20261 min read8 references
Short answer

In practice, no; the chance that a biopsy or surgery makes cancer spread to other parts of the body is very low, and doctors use standard methods to prevent it [1]. "Seeding" of tumour cells along the needle track is real but rare [2]; for example, in one review it was seen in about 3 in every 100 patients after a biopsy of liver cancer [6]. In most cases, cancer cannot be confirmed without a biopsy [4]; so fear of a biopsy should not delay diagnosis and treatment.

Key points

  • Surgeons use standard methods to prevent the spread of cancer cells; for example, they use separate instruments for each area [1].
  • Besides confirming cancer, a biopsy provides information such as the tumour type and genetic mutations that determine treatment [4, 5].

What studies have shown about some types of biopsy

SituationFindingPractical point
Needle biopsy of liver cancer (HCC)In a review of 8 studies, needle-track seeding was seen in about 3 in every 100 patients [6]In a patient with cirrhosis, a characteristic imaging pattern is often enough for the diagnosis, and a biopsy is done only when needed [7]
EUS-FNA in pancreatic cancerIn 2034 patients who had surgery, EUS-FNA was not associated with increased mortality [3]In another study, it was not associated with more recurrence in the stomach or peritoneum [8]
Needle biopsies in different organsSeeding is rare, but the risk differs by organ and technique [2]The treatment team chooses the biopsy method based on the tumour site and the treatment plan
CT scan during a lung biopsy showing the biopsy needle in a lung mass
CT-guided biopsy: a thin needle (the bright line), whose position can be seen on the images, is guided precisely into a lung mass. This method allows a firm diagnosis without open surgery.Image: Hellerhoff · CC BY-SA 3.0 · Wikimedia Commons

Why does a biopsy matter?

  1. 1

    Confirming the diagnosis

    Blood tests and imaging alone do not confirm cancer; in most cases a biopsy is needed [4].

  2. 2

    Determining the type of tumour

    The pathologist records the type and features of the tumour in the pathology report, which helps in choosing treatment [4].

  3. 3

    Molecular testing

    For example, in advanced non-small cell lung cancer, testing the tumour tissue for mutations such as EGFR and ALK makes targeted treatment possible [5].

When should I call my doctor?

Before a biopsy, share your worries with your doctor and ask: why is this biopsy needed? Which method has been chosen and why? How will the result affect treatment?

After a biopsy, if you have a temperature of 38 °C or more, bleeding that does not stop, severe pain or shortness of breath, contact your doctor or treatment centre straight away.

Related questions

I have heard that if a tumour is "opened" and exposed to air, the cancer spreads; is that true?

No. Contact with air does not make a tumour grow faster or make cancer spread [1].

Can treatment be started without a biopsy?

In most cancers, no, because the type of tumour and its features determine treatment [4]. There are exceptions; for example, in liver cancer with cirrhosis, a characteristic imaging pattern is often enough for the diagnosis [7].

Related cancer types

References

8 references
Show all references, 6 with a study cardClose the reference list

Numbers in the text, such as [1], refer to these sources. Sources with a “Study card” button are summarised in the site’s evidence library.

  1. 1
    Common Cancer Myths and MisconceptionsNational Cancer Institute · cancer.gov
    Source Back to text: 1 2 3
  2. 2
    Tumour seeding following percutaneous needle biopsy: The real story!Robertson E, Baxter G · Clinical Radiology · 2011;66:1007-1014
    Study cardDOI Back to text: 1 2
  3. 3
    Preoperative endoscopic ultrasound-guided fine needle aspiration does not impair survival of patients with resected pancreatic cancerNgamruengphong S, Swanson KM, Shah ND, Wallace MB · Gut · 2015;64:1105-1110
  4. 4
    Tests and Procedures Used to Diagnose CancerNational Cancer Institute · cancer.gov
    Source Back to text: 1 2 3 4 5
  5. 5
    Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upHendriks LE, Kerr KM, Menis J, Mok TS, Nestle U, Passaro A, et al · Annals of Oncology · 2023;34:339-357
    Study cardDOIPubMed Back to text: 1 2
  6. 6
    Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysisSilva MA, Hegab B, Hyde C, Guo B, Buckels JAC, Mirza DF · Gut · 2008;57:1592-1596
    Study cardDOI Back to text: 1 2
  7. 7
    EASL Clinical Practice Guidelines on the management of hepatocellular carcinomaEuropean Association for the Study of the Liver · J Hepatol · 2025;82:315-374
    Study cardDOIPubMed Back to text: 1 2
  8. 8
    Risk of gastric or peritoneal recurrence, and long-term outcomes, following pancreatic cancer resection with preoperative endosonographically guided fine needle aspirationNgamruengphong S, Xu C, Woodward T, Raimondo M, Stauffer J, Asbun H, et al · Endoscopy · 2013;45:619-626

This page is based on reputable scientific sources and was last updated on 28 October 2026. The content of this website is for educational and informational purposes only and does not replace consultation, diagnosis or treatment by a specialist physician. Consult your treating physician about any treatment decision.